BRNS

#4173
Barinthus Biotherapeutics plc - American Depositary Shares
0.6 8 USD
+4.62%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.68
0.68
Range Annuel
0.51
2.92
Changement quotidien
+4.62%
Changement Mensuel
+11.48%
Evolution sur 6 mois
-15.00%
Changement Annuel
-33.98%
Clôture Précédente
0.6 5
Open
0.6 8
Low
0.6 8
High
0.6 8
Volume
1
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 27.78 M
  • Employee 14
  • Founded 2016
  • CEO N/A
  • Website www.barinthusbio.com
  • Headquarter United Kingdom
  • FIGI BBG00ZZPCP09
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.43
ratio cours/chiffre d'affaires
—

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.

Nouvelles